Emerald Health Therapeutics, Inc. (CVE:EMH – Get Free Report) was down 3.8% during trading on Wednesday . The stock traded as low as C$0.25 and last traded at C$0.26. Approximately 384,329 shares were traded during trading, a decline of 40% from the average daily volume of 644,760 shares. The stock had previously closed at C$0.27.
Emerald Health Therapeutics Stock Performance
The business’s fifty day moving average is C$0.26 and its 200-day moving average is C$0.26. The company has a quick ratio of 2.61, a current ratio of 2.97 and a debt-to-equity ratio of 35.45. The company has a market cap of C$52.28 million and a PE ratio of -0.37.
About Emerald Health Therapeutics
Emerald Health Therapeutics, Inc, together with its subsidiaries, produces and sells medical cannabis for medical purpose in Canada. The company is also involved in developing natural health products. It offers dried cannabis strains, pre-rolls, and cannabis oil products to its medical patients. The company was formerly known as T-Bird Pharma Inc and changed its name to Emerald Health Therapeutics, Inc in June 2015.
Further Reading
- Five stocks we like better than Emerald Health Therapeutics
- The Role Economic Reports Play in a Successful Investment Strategy
- 3 Micro-Caps Set for Major Moves: Balancing Risk and Opportunity
- What is the S&P/TSX Index?
- Autodesk Named a “Top Pick” by Morgan Stanley—Is It Time to Buy?
- How to Use Stock Screeners to Find Stocks
- 4 Quirky ETFs With Big Potential for Impressive Gains
Receive News & Ratings for Emerald Health Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Emerald Health Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
